CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway
Authors:
- 1 January 2015
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 456 (1) , 373-379
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81160305)
This publication has 23 references indexed in Scilit:
- Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivoMolecular Medicine Reports, 2013
- Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Cancer Cells Promotes Cell Survival and Proliferation in Hepatocellular CarcinomaDigestive Diseases and Sciences, 2013
- Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expressionOncology Reports, 2012
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4Cancer Cell, 2012
- Hepatocellular carcinomaThe Lancet, 2012
- Endotoxin Accumulation Prevents Carcinogen-Induced Apoptosis and Promotes Liver Tumorigenesis in RodentsHepatology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: Potential therapeutic application for treatment of gliomasNeuro-Oncology, 2008
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Cancer burden in the year 2000. The global pictureEuropean Journal of Cancer, 2001